A socio-demographic study on seroprevalence of SARS-CoV-2 antibodies and associated factors in a rural population in Andhra Pradesh
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20233467Keywords:
Antibodies, Cross-sectional, SARS Cov2, Sampling interval, Seroprevalence, VaccinationAbstract
Background: SARS-CoV-2 is an enveloped, single stranded RNA beta corona virus that belongs to the family Coronaviridae. The S and N proteins are the principal immunogens used for the detection of anti – SARS-CoV-2 specific antibodies.2 The first subunit (S1) mediates the attachment of the virus to human cells via its receptor - binding domain (RBD), and the second one (S2) mediates membrane fusion for viral entry. Antibodies that bind to the S protein can neutralize corona viruses.
Methods: It was a community based analytical cross-sectional study done in rural areas of Eluru district, A.P. State. From each village 30 members were selected by using systematic random sampling. A sample of 120 was included. Blood samples from the selected individuals were taken Humoral responses (Ig G) were assessed using an ICMR approved Micro well ELISA test for the semi-quantitative detection of COVID 19 (SARS-CoV-2) neutralizing antibodies in Human serum samples.
Results: In the present study 46 (28.3%) had higher education, 15 (12.5 %) belong to farmers, 84 (70%) of them belong to Hindus, 94 (78.3%) of them belong to nuclear family. History of COVID 19 (p=0.02), period from recent dose of covid vaccination (p=0.04) were found to be statistically significant.
Conclusions: High seroprevalence in this study suggests that COVID-19 vaccination remains the best method to control the COVID-19 pandemic. It is necessary to encourage the public to take vaccination.
Metrics
References
Lu J, du Plessis L, Liu Z, Hill V, Kang M, Lin H, Sun J, et al. Genomic epidemiology of SARS-CoV-2 in Guangdong province, China. Cell. 2020;181(5):997-1003.
Henss L, Scholz T, Von Rhein C, Wieters I, Borgans F, Eberhardt FJ, et al. Analysis of humoral immune responses in patients with severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis. 2021;223(1):56-61.
Mesin L, Schiepers A, Ersching J, Barbulescu A, Cavazzoni CB, Angelini A, et al. Restricted clonality and limited germinal center reentry characterize memory B cell reactivation by boosting. Cell. 2020;180(1):92-106.
Goel RR, Apostolidis SA, Painter MM, Mathew D, Pattekar A, Kuthuru O, et al. Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination. Sci Immunol. 2021;6(58): eabi6950.
Muro A, Belhassen-García M, Bellido JL, Juanes HL, Vicente B, Pendones J, et al. Seroprevalence of sarscov-2 antibodies and factors associated with seropositivity at the University of Salamanca: The diancusal study. J Clin Medi. 2021;10(15):3214.
Bawa MS, Desale AV, Pandve HT, Nimbalkar AV, Patil TV, Gophane LP, et al. Population-based repeat cross-sectional seroprevalence survey of SARS-CoV-2 IgG antibodies in Pimpri Chinchwad Municipal Corporation Area, Maharashtra, India. J Fam Med Prim Care. 2022;11(6):2789.
George CE, Inbaraj LR, Chandrasingh S, De Witte LP. High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond? Epidemiol Infect. 2021;149:1-6.
Kumar D, Burma A, Mandal AK. A seroprevalence study of Covid 19 antibody after 1st wave of the pandemic in South Andaman district, India. Clin Epidemiol Global Heal. 2021;12:100901.
Sekine T, Perez-Potti A, Rivera-Ballesteros O, Strålin K, Gorin JB, Olsson A, et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell. 2020;183(1):158-68.
